Aerovate Therapeutics (NASDAQ:AVTE – Get Free Report) will likely be announcing its earnings results before the market opens on Monday, March 24th. Analysts expect the company to announce earnings of ($0.40) per share for the quarter.
Aerovate Therapeutics Stock Performance
AVTE opened at $2.47 on Monday. The firm’s fifty day moving average is $2.50 and its two-hundred day moving average is $2.40. The firm has a market cap of $71.32 million, a PE ratio of -0.83 and a beta of 1.01. Aerovate Therapeutics has a twelve month low of $1.25 and a twelve month high of $32.42.
About Aerovate Therapeutics
See Also
- Five stocks we like better than Aerovate Therapeutics
- What Are Dividend Achievers? An Introduction
- How to Build the Ultimate Everything ETF Portfolio
- Want to Profit on the Downtrend? Downtrends, Explained.
- Dutch Bros or Starbucks: Which Coffee Stock Has More Growth?
- How Can Investors Benefit From After-Hours Trading
- 3 Stocks With High ROE and Market-Beating Growth Potential
Receive News & Ratings for Aerovate Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aerovate Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.